| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleosome binding | 4.93e-04 | 98 | 7 | 2 | GO:0031491 | |
| GeneOntologyBiologicalProcess | nucleosome disassembly | 2.27e-05 | 22 | 7 | 2 | GO:0006337 | |
| GeneOntologyBiologicalProcess | protein-DNA complex disassembly | 2.72e-05 | 24 | 7 | 2 | GO:0032986 | |
| GeneOntologyCellularComponent | motile cilium | 5.71e-03 | 355 | 7 | 2 | GO:0031514 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.47e-05 | 22 | 6 | 2 | MM1370 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 4.15e-05 | 24 | 6 | 2 | M13404 | |
| Pubmed | 1.04e-07 | 3 | 7 | 2 | 26842758 | ||
| Pubmed | 9.72e-07 | 8 | 7 | 2 | 20599239 | ||
| Pubmed | Histone modifications defining active genes persist after transcriptional and mitotic inactivation. | 3.16e-06 | 14 | 7 | 2 | 15616580 | |
| Pubmed | A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation. | 2.18e-05 | 36 | 7 | 2 | 29089422 | |
| Pubmed | Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes. | 4.76e-05 | 53 | 7 | 2 | 21532573 | |
| Pubmed | ELOF1 is a transcription-coupled DNA repair factor that directs RNA polymerase II ubiquitylation. | 5.91e-05 | 59 | 7 | 2 | 34108663 | |
| Pubmed | 6.11e-05 | 60 | 7 | 2 | 21555518 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 6.78e-05 | 440 | 7 | 3 | 34244565 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | 9.54e-05 | 1451 | 7 | 4 | 30550785 | |
| Pubmed | 9.57e-05 | 75 | 7 | 2 | 29459360 | ||
| Pubmed | An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. | 1.41e-04 | 91 | 7 | 2 | 20362542 | |
| Pubmed | 1.81e-04 | 103 | 7 | 2 | 32744500 | ||
| Pubmed | 2.00e-04 | 634 | 7 | 3 | 34591612 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 5.97e-03 | 797 | 7 | 2 | chr19p13 | |
| Coexpression | GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN | 1.30e-04 | 66 | 7 | 2 | M12812 | |
| Coexpression | MCCLUNG_COCAIN_REWARD_4WK | 1.64e-04 | 74 | 7 | 2 | M1600 | |
| Coexpression | MCCLUNG_COCAIN_REWARD_4WK | 1.73e-04 | 76 | 7 | 2 | MM682 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | 8.72e-04 | 790 | 7 | 3 | M12490 | |
| Coexpression | GSE12366_GC_BCELL_VS_PLASMA_CELL_UP | 1.15e-03 | 197 | 7 | 2 | M3166 | |
| Coexpression | GSE45365_CD8A_DC_VS_CD11B_DC_UP | 1.15e-03 | 197 | 7 | 2 | M9997 | |
| Coexpression | GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_UP | 1.16e-03 | 198 | 7 | 2 | M4736 | |
| Coexpression | GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | 1.17e-03 | 199 | 7 | 2 | M7524 | |
| Coexpression | GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP | 1.17e-03 | 199 | 7 | 2 | M3328 | |
| Coexpression | GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP | 1.17e-03 | 199 | 7 | 2 | M4427 | |
| Coexpression | GSE22886_TCELL_VS_BCELL_NAIVE_UP | 1.17e-03 | 199 | 7 | 2 | M4425 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_DN | 1.19e-03 | 200 | 7 | 2 | M3960 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_UP | 1.19e-03 | 200 | 7 | 2 | M3728 | |
| Coexpression | GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP | 1.19e-03 | 200 | 7 | 2 | M9686 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_UP | 1.19e-03 | 200 | 7 | 2 | M3906 | |
| Coexpression | GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_UP | 1.19e-03 | 200 | 7 | 2 | M5097 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_UP | 1.19e-03 | 200 | 7 | 2 | M4497 | |
| Coexpression | GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_UP | 1.19e-03 | 200 | 7 | 2 | M6429 | |
| Coexpression | GSE360_DC_VS_MAC_L_MAJOR_UP | 1.19e-03 | 200 | 7 | 2 | M5181 | |
| Coexpression | GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_UP | 1.19e-03 | 200 | 7 | 2 | M6551 | |
| Coexpression | GSE17721_CTRL_VS_LPS_0.5H_BMDC_DN | 1.19e-03 | 200 | 7 | 2 | M3680 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP | 1.19e-03 | 200 | 7 | 2 | M3446 | |
| Coexpression | GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_DN | 1.19e-03 | 200 | 7 | 2 | M4326 | |
| Coexpression | LOPEZ_MBD_TARGETS | 1.50e-03 | 953 | 7 | 3 | M4120 | |
| CoexpressionAtlas | B cells, B.Pl.AA4+220-.BM, CD138+ AA4.1+ CD43- CD45R-, Bone marrow, avg-3 | 1.35e-04 | 339 | 7 | 3 | GSM777027_500 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-4|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.21e-06 | 181 | 7 | 3 | 51d91b923920463245e95d65c6a5197e21d34d73 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-04 | 123 | 7 | 2 | 511b7c20a4a85e49980936d52af7dbca19bb848e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.64e-04 | 161 | 7 | 2 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | Immune_cells-pro-B|Immune_cells / Lineage and Cell class | 3.01e-04 | 172 | 7 | 2 | 096636f2589fa56d15942aac96641c16fd5fa78d | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Deuterosomal|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.01e-04 | 172 | 7 | 2 | 08ad76412c9cc3504141797b44b88478ced87476 | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-5|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 3.01e-04 | 172 | 7 | 2 | 6b8a8d3b97c10b9d092307eed3cacbd2745df185 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.05e-04 | 173 | 7 | 2 | 4f0c065e876197ad8cae7856669f09e37ecafa3f | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.05e-04 | 173 | 7 | 2 | 9bbea566964281f47bf75d665b7d69ba8326e207 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-04 | 174 | 7 | 2 | 268be5e7d2a18b866770b7cdb966c3958c7e6534 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-04 | 174 | 7 | 2 | 4cdf2eedc28d88d18241ee390092426fdf849e79 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-04 | 174 | 7 | 2 | a9f34d1237f335d27c5560ff514368f4709f9144 | |
| ToppCell | Immune_cells-pro-B|World / Lineage and Cell class | 3.08e-04 | 174 | 7 | 2 | e173adbf5789dfa20f3cbc668efde5f0992ac219 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 176 | 7 | 2 | 29cda51a99100ddd2928cadc92da40f001d7e1f4 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 176 | 7 | 2 | 01774a86d7d92f31a056b753f9844f923038003e | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 176 | 7 | 2 | d43d9e86c4d4fa1e88fbf2b899ac7143717aac90 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.23e-04 | 178 | 7 | 2 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.26e-04 | 179 | 7 | 2 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.34e-04 | 181 | 7 | 2 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.37e-04 | 182 | 7 | 2 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.37e-04 | 182 | 7 | 2 | e44c4810dc7d51a76b86d7623f8e4c4d8b4bf2fc | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 3.37e-04 | 182 | 7 | 2 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Immune_cells-large_pre-B.|World / Lineage and Cell class | 3.41e-04 | 183 | 7 | 2 | 81b5ed6ed661d2d6a9b807fefd2f0d59bd4ea77e | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.45e-04 | 184 | 7 | 2 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.48e-04 | 185 | 7 | 2 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.48e-04 | 185 | 7 | 2 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 3.48e-04 | 185 | 7 | 2 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 3.48e-04 | 185 | 7 | 2 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | 18-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 3.52e-04 | 186 | 7 | 2 | 58ab1360a1730655a5939295ba05997ac4a2d14e | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.52e-04 | 186 | 7 | 2 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.56e-04 | 187 | 7 | 2 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.56e-04 | 187 | 7 | 2 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|Epithelial_cells / Location, Cell class and cell subclass | 3.56e-04 | 187 | 7 | 2 | 3cea677279e71fdb9879530dea10a5e6393beacd | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 3.56e-04 | 187 | 7 | 2 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.60e-04 | 188 | 7 | 2 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.60e-04 | 188 | 7 | 2 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|tumor_Lung / Location, Cell class and cell subclass | 3.60e-04 | 188 | 7 | 2 | 26326b4e298e33f9ba393fc632238aa8c54b1ea3 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 3.60e-04 | 188 | 7 | 2 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.64e-04 | 189 | 7 | 2 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 3.64e-04 | 189 | 7 | 2 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 3.64e-04 | 189 | 7 | 2 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-SMG_serous_secreting_cell-SMG_serous_(nasal)-SMG_serous_(nasal)_L.0.6.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-04 | 189 | 7 | 2 | 29423dc66a8af71293b2e1670acc6c34dfe63608 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.64e-04 | 189 | 7 | 2 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.64e-04 | 189 | 7 | 2 | a3cd4c2da4feb9bdcd8957f3e344d095da1367b8 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.64e-04 | 189 | 7 | 2 | 93b1026bb1ba759e5704561c9a5de14a30c08894 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.67e-04 | 190 | 7 | 2 | 69c5c4d5f4fb6e5ae2c9dbf9d209faf093c3f769 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.67e-04 | 190 | 7 | 2 | 17829f4de31b3d9e4d71ba4817d18842aa699773 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.71e-04 | 191 | 7 | 2 | 8a5a2188b13ef4bbfd626a42565566708a751c1b | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.71e-04 | 191 | 7 | 2 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.71e-04 | 191 | 7 | 2 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.71e-04 | 191 | 7 | 2 | e314dd8f1a841cab847ae3703bedfe1bc623ac61 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.71e-04 | 191 | 7 | 2 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.71e-04 | 191 | 7 | 2 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | Ciliated-cil-3|World / Class top | 3.75e-04 | 192 | 7 | 2 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.75e-04 | 192 | 7 | 2 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-04 | 194 | 7 | 2 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.83e-04 | 194 | 7 | 2 | b0477583301dc6d9767b667bd2f8f94fbfaa6f81 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.87e-04 | 195 | 7 | 2 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | (2)_B_cells-(2)_Plasma_cells|(2)_B_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.91e-04 | 196 | 7 | 2 | cc4f59b885d58e43471e85c51d8e366e68d10846 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.91e-04 | 196 | 7 | 2 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.91e-04 | 196 | 7 | 2 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.91e-04 | 196 | 7 | 2 | 69f5081e06d84ec1d9695762df801a9d0df1984b | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.91e-04 | 196 | 7 | 2 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.91e-04 | 196 | 7 | 2 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.95e-04 | 197 | 7 | 2 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | B_cell_maturation-CD34+_pro-B|B_cell_maturation / Lineage and Cell class | 3.99e-04 | 198 | 7 | 2 | 5737606e5e3dc56f11fdf70166caf4ba4a81bc9d | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.99e-04 | 198 | 7 | 2 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 | |
| ToppCell | erythropoietic-Basophilic_Erythroblast|erythropoietic / Lineage and Cell class | 4.03e-04 | 199 | 7 | 2 | 39c4adef3e02f948414f866aa22ac76f44b7b7db | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.03e-04 | 199 | 7 | 2 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | PBMC-Severe|PBMC / Compartment, Disease Groups and Clusters | 4.03e-04 | 199 | 7 | 2 | b428d95d3c90b28f658f652a768588a8ced4abd9 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 4.03e-04 | 199 | 7 | 2 | 6f159c1215439ec22374903124085746fa8da333 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.03e-04 | 199 | 7 | 2 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-04 | 200 | 7 | 2 | af6a551f83808c1c839df7ba7b1702ca28ea6e1b | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-04 | 200 | 7 | 2 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-04 | 200 | 7 | 2 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Transverse-B_cell-B_cell_IgA_Plasma|B_cell / Region, Cell class and subclass | 4.07e-04 | 200 | 7 | 2 | 210c4a9221cf5c035c4e6c01755d17fe3b80a3fe | |
| ToppCell | (2)_B_cell-(20)_B_cell_IgA_Plasma|(2)_B_cell / shred on Cell_type and subtype | 4.07e-04 | 200 | 7 | 2 | 42afce995f9a7de0406cc836e1f09b3f168a066c | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-04 | 200 | 7 | 2 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Caecum-B_cell-B_cell_IgA_Plasma|B_cell / Region, Cell class and subclass | 4.07e-04 | 200 | 7 | 2 | 9bed2f22b71ebcf96239c5639c1a67602724f3de | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-04 | 200 | 7 | 2 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Sigmoid-B_cell-B_cell_IgA_Plasma|B_cell / Region, Cell class and subclass | 4.07e-04 | 200 | 7 | 2 | 5af830c85305db3db5ebd6cedc9c1a96b67ce126 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Differentiating_Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.07e-04 | 200 | 7 | 2 | a552a99f5e4fa00dfb7775e5a3e1f62f1530d104 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-04 | 200 | 7 | 2 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-04 | 200 | 7 | 2 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-04 | 200 | 7 | 2 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-04 | 200 | 7 | 2 | 73ac1cf40ddd764be1100cbfaaa29563665457d8 | |
| ToppCell | (2)_B_cell-(21)_B_cell_IgG_Plasma|(2)_B_cell / shred on Cell_type and subtype | 4.07e-04 | 200 | 7 | 2 | 2831060d52b210f8927527810611735a99b61999 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-04 | 200 | 7 | 2 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| Drug | Amphoterin | 7.66e-06 | 139 | 7 | 3 | CID003496889 | |
| Drug | Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; HL60; HG-U133A | 2.08e-05 | 194 | 7 | 3 | 1437_DN | |
| Drug | Tetrahydroalstonine [6474-90-4]; Down 200; 11.4uM; HL60; HG-U133A | 2.24e-05 | 199 | 7 | 3 | 1756_DN | |
| Drug | NSC401575 | 6.57e-04 | 129 | 7 | 2 | CID000003165 | |
| Drug | AC1OCADI | 6.67e-04 | 130 | 7 | 2 | CID006914639 | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; HL60; HG-U133A | 1.26e-03 | 179 | 7 | 2 | 1398_DN | |
| Drug | Laudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; HL60; HG-U133A | 1.47e-03 | 194 | 7 | 2 | 1741_DN | |
| Drug | Corticosterone [50-22-6]; Down 200; 11.6uM; HL60; HT_HG-U133A | 1.47e-03 | 194 | 7 | 2 | 1307_DN | |
| Drug | Chlorhexidine [55-56-1]; Up 200; 8uM; HL60; HG-U133A | 1.49e-03 | 195 | 7 | 2 | 2025_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | 1.49e-03 | 195 | 7 | 2 | 1561_DN | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; PC3; HT_HG-U133A | 1.49e-03 | 195 | 7 | 2 | 4300_UP | |
| Drug | Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; PC3; HT_HG-U133A | 1.49e-03 | 195 | 7 | 2 | 6339_DN | |
| Drug | Chlorphensin carbamate [886-74-8]; Down 200; 16.2uM; HL60; HG-U133A | 1.50e-03 | 196 | 7 | 2 | 1432_DN | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; HL60; HG-U133A | 1.50e-03 | 196 | 7 | 2 | 1593_DN | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 1.50e-03 | 196 | 7 | 2 | 2_DN | |
| Drug | staurosporine; Down 200; 0.01uM; SKMEL5; HG-U133A | 1.50e-03 | 196 | 7 | 2 | 508_DN | |
| Drug | Norfloxacin [70458-96-7]; Down 200; 12.6uM; HL60; HG-U133A | 1.52e-03 | 197 | 7 | 2 | 1406_DN | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; PC3; HG-U133A | 1.52e-03 | 197 | 7 | 2 | 1944_DN | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; HL60; HG-U133A | 1.52e-03 | 197 | 7 | 2 | 1436_DN | |
| Drug | Metformin hydrochloride [1115-70-4]; Up 200; 24.2uM; HL60; HT_HG-U133A | 1.52e-03 | 197 | 7 | 2 | 1858_UP | |
| Drug | Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; PC3; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 5837_UP | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Down 200; 8uM; HL60; HG-U133A | 1.54e-03 | 198 | 7 | 2 | 1553_DN | |
| Drug | sulindac; Up 200; 100uM; MCF7; HG-U133A | 1.54e-03 | 198 | 7 | 2 | 168_UP | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HG-U133A | 1.55e-03 | 199 | 7 | 2 | 1933_DN | |
| Drug | Loxapine succinate [27833-64-3]; Down 200; 9uM; HL60; HG-U133A | 1.55e-03 | 199 | 7 | 2 | 2016_DN | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 1.55e-03 | 199 | 7 | 2 | 61_DN | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; HL60; HG-U133A | 1.55e-03 | 199 | 7 | 2 | 1588_DN | |
| Drug | CAY10397; Down 200; 10uM; PC3; HT_HG-U133A | 1.55e-03 | 199 | 7 | 2 | 7071_DN | |
| Drug | PHA-00816795 [212631-79-3]; Down 200; 10uM; PC3; HT_HG-U133A | 1.55e-03 | 199 | 7 | 2 | 7072_DN | |
| Drug | Cefotaxime sodium salt [64485-93-4]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.57e-03 | 200 | 7 | 2 | 5830_UP | |
| Drug | melanin | 2.01e-03 | 227 | 7 | 2 | CID006325610 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KMAQYLEEERHMREE | 286 | Q16204 | |
| EFKKYEMMKEHERRE | 176 | P80303 | |
| EHRDYVMRMKEFERE | 91 | P17568 | |
| KEYREAMERMMHEEH | 726 | Q8IY82 | |
| EMECHEYMRRRMDAV | 271 | Q9C0B2 | |
| IARHEEEFDLFMRMD | 1306 | P51532 | |
| DDLYAEQMEREMRHK | 761 | Q9Y5B9 |